Skip to main content

Table 4 Cost-effectiveness analysis for the base case

From: Cost-effectiveness analysis of coronary arteries bypass grafting (CABG) and percutaneous coronary intervention (PCI) through drug stent in iran: a comparative study

 

Strategies

QALYs

Incremental QALYs

Costs($)

Incremental Costs

ICER

 

ACER

SAQ

PCI

1.57

85634

 

54544

CABG

3.33

1.75

56618

−29016

−16581

Dominant

17002

SF-36

PCI

1.68

 

85634

 

 

50973

CABG

2.52

0.84

56618

−29016

−34543

Dominant

22467